Fiche publication
Date publication
mai 2026
Journal
The New England journal of medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Pr AUBIN François
Tous les auteurs :
Bernigaud C, Do-Pham G, Guichard E, Beylot-Barry M, Goujon E, Isnard C, Beneton N, Samimi M, Tedbirt B, Adamski H, Azib S, Mahé E, Michel C, Perrot JL, Acquitter M, Bursztejn AC, Chaby G, Caux F, Passeron T, Vanhaecke C, Mahé A, Leccia MT, Barbarot S, Lenormand C, Aubin F, Foulet F, Grégoire L, Giraudeau B, Chosidow O
Lien Pubmed
Résumé
Severe scabies, a rare parasitic skin disease characterized by abundant skin mites, may be life-threatening and poses public health concerns worldwide. A combination of standard-dose oral ivermectin and topical scabicides is recommended for treatment. However, data from randomized clinical trials are lacking, and the probability of cure is uncertain. Ivermectin at higher doses has been effective in the treatment of some parasitic diseases.
Mots clés
Adult, Aged, Animals, Female, Humans, Male, Middle Aged, Young Adult, Administration, Oral, Antiparasitic Agents, administration & dosage, Drug Therapy, Combination, adverse effects, Insecticides, administration & dosage, Ivermectin, administration & dosage, Permethrin, administration & dosage, Sarcoptes scabiei, drug effects, Scabies, diagnosis, Skin Cream, administration & dosage, Administration, Cutaneous, Dermoscopy, Skin, diagnostic imaging, Severity of Illness Index, Emollients, administration & dosage, Dose-Response Relationship, Drug, Treatment Outcome, Aged, 80 and over
Référence
N Engl J Med. 2026 05 7;394(18):1814-1823
